Related Experiment Video
Updated: Aug 8, 2026

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene
Published on: December 31, 2014
The c-Myc target gene PRDX3 is required for mitochondrial homeostasis and neoplastic transformation
Diane R Wonsey1, Karen I Zeller, Chi V Dang
1Program in Human Genetics and Molecular Biology and Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Abstract:
Deregulated expression of the c-Myc transcription factor is found in a wide variety of human tumors. Because of this significant role in oncogenesis, considerable effort has been devoted to elucidating the molecular program initiated by deregulated c-myc expression. The primary transforming activity of Myc is thought to arise through transcriptional regulation of numerous target genes. Thus far, Myc target genes involved in mitochondrial function have not been characterized in depth. Here, we describe a nuclear c-Myc target gene, PRDX3, which encodes a mitochondrial protein of the peroxiredoxin gene family. Expression of PRDX3 is induced by the mycER system and is reduced in c-myc(-/-) cells. Chromatin immunoprecipitation analysis spanning the entire PRDX3 genomic sequence reveals that Myc binds preferentially to a 930-bp region surrounding exon 1. We show that PRDX3 is required for Myc-mediated proliferation, transformation, and apoptosis after glucose withdrawal. Results using mitochondria-specific fluorescent probes demonstrate that PRDX3 is essential for maintaining mitochondrial mass and membrane potential in transformed rat and human cells. These data provide evidence that PRDX3 is a c-Myc target gene that is required to maintain normal mitochondrial function.
Insights
This study identifies PRDX3 as a novel nuclear c-Myc target gene crucial for mitochondrial function. PRDX3 supports cancer cell proliferation and survival by maintaining mitochondrial integrity.
Area of Science:
- Molecular Biology
- Cancer Research
- Mitochondrial Biology
Background:
- Deregulated c-Myc is implicated in numerous human cancers.
- c-Myc exerts its oncogenic effects primarily through transcriptional regulation of target genes.
- The role of c-Myc in regulating mitochondrial function is not fully understood.
Purpose of the Study:
- To identify and characterize novel c-Myc target genes involved in mitochondrial function.
- To elucidate the role of PRDX3, a peroxiredoxin family member, as a c-Myc target gene.
- To investigate the impact of PRDX3 on mitochondrial homeostasis and cancer cell phenotypes.
Main Methods:
- Utilized the mycER system and c-myc(-/-) cells to study PRDX3 expression.
- Performed chromatin immunoprecipitation (ChIP) to identify Myc binding sites on the PRDX3 gene.
- Employed mitochondria-specific fluorescent probes to assess mitochondrial function.
Main Results:
- PRDX3 expression is induced by Myc and reduced in c-myc deficient cells.
- Myc binds to a specific region of the PRDX3 genomic locus.
- PRDX3 is essential for Myc-mediated proliferation, transformation, and resistance to glucose withdrawal.
- PRDX3 maintains mitochondrial mass and membrane potential in cancer cells.
Conclusions:
- PRDX3 is a direct nuclear c-Myc target gene.
- PRDX3 plays a critical role in maintaining mitochondrial function in cancer cells.
- Targeting PRDX3 may offer a therapeutic strategy for c-Myc-driven cancers.
Related Concept Videos
Master Transcription Regulators
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Mitogens and the Cell Cycle
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Induced Pluripotent Stem Cells
Somatic cells are...

